National Vision’s first quarter was marked by momentum in its core transformation strategy, with results surpassing Wall Street expectations and prompting a strong market response. Management highlighted successful execution on strategic initiatives targeting three core customer segments—managed care, progressive, and outside prescription buyers—which contributed to improved same-store sales and customer traffic. CEO Reade Fahs noted these efforts have helped offset softness among lower-income customers, stating, “Our value offering positions us well, particularly in this environment.” The company also pointed to effective pricing actions and an expanded product mix as key factors behind the quarter’s gains.

Is now the time to buy EYE? Find out in our full research report (it’s free).

While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions National Vision’s Q1 Earnings Call

• Simeon Gutman (Morgan Stanley) asked if average ticket growth could accelerate further as product mix continues to evolve; CEO Alex Wilkes replied there is ample runway for ticket expansion without conversion loss.
• Zachary Fadem (Wells Fargo) inquired about income demographics and the impact of higher-income customers; CEO Reade Fahs explained that higher-income consumers offset softness among lower-income segments.
• Brandon Cheatham (Citi) sought details on exposure to China tariffs and supply chain flexibility; Wilkes stated less than 10% of cost of goods is exposed to China, with diversified sourcing reducing risk.
• Kate McShane (Goldman Sachs) questioned the ability to fully mitigate tariff impacts; CFO Chris Laden confirmed planned pricing and cost actions are expected to offset the $10–15 million incremental product costs not included in guidance.
• Robert Ohmes (Bank of America) asked whether low-income customer weakness reflected deferral or share loss; Fahs noted low-income shoppers are more financially strained, but overall managed care volumes remain stable.

Catalysts in Upcoming Quarters

In the coming quarters, our team will be watching (1) the effectiveness of new product introductions and pricing strategies in sustaining average ticket and traffic gains, (2) the rollout and impact of the new CRM and digital marketing tools on customer engagement, and (3) ongoing cost-saving initiatives and their ability to neutralize external cost pressures including tariffs. The seamless transition to new leadership will also be a key area of focus.

National Vision currently trades at $24.41, up from $13.33 just before the earnings. Is there an opportunity in the stock?The answer lies in our full research report (it’s free).

High-Quality Stocks for All Market Conditions

Market indices reached historic highs following Donald Trump’s presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth.

While this has caused many investors to adopt a "fearful" wait-and-see approach, we’re leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.